Schwab M - Search Results

1

Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine.

Kaskas BA, Louis E, Hindorf U, Schaeffeler E, Deflandre J, Graepler F, Schmiegelow K, Gregor M, Zanger UM, Eichelbaum M, Schwab M. Kaskas BA, et al. Among authors: schwab m. Gut. 2003 Jan;52(1):140-2. doi: 10.1136/gut.52.1.140. Gut. 2003. PMID: 12477776 Free PMC article.

2

High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC.

Schaeffeler E, Lang T, Zanger UM, Eichelbaum M, Schwab M. Schaeffeler E, et al. Among authors: schwab m. Clin Chem. 2001 Mar;47(3):548-55. Clin Chem. 2001. PMID: 11238310

3

Adherence to thiopurine treatment in out-patients with Crohn's disease.

Bokemeyer B, Teml A, Roggel C, Hartmann P, Fischer C, Schaeffeler E, Schwab M. Bokemeyer B, et al. Among authors: schwab m. Aliment Pharmacol Ther. 2007 Jul 15;26(2):217-25. doi: 10.1111/j.1365-2036.2007.03365.x. Aliment Pharmacol Ther. 2007. PMID: 17593067 Free article.

4

Shortcoming in the diagnosis of TPMT deficiency in a patient with Crohn's disease using phenotyping only.

Schwab M, Schaeffeler E, Marx C, Zanger U, Aulitzky W, Eichelbaum M. Schwab M, et al. Gastroenterology. 2001 Aug;121(2):498-9. Gastroenterology. 2001. PMID: 11487563 No abstract available.

5

[Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].

Schwab M, Herrlinger K, Schaeffeler E, Stange EF. Schwab M, et al. Dtsch Med Wochenschr. 2003 Feb 21;128(8):378-85. doi: 10.1055/s-2003-37378. Dtsch Med Wochenschr. 2003. PMID: 12594624 Review. German. No abstract available.

6

A novel TPMT missense mutation associated with TPMT deficiency in a 5-year-old boy with ALL.

Schaeffeler E, Stanulla M, Greil J, Schrappe M, Eichelbaum M, Zanger UM, Schwab M. Schaeffeler E, et al. Among authors: schwab m. Leukemia. 2003 Jul;17(7):1422-4. doi: 10.1038/sj.leu.2402981. Leukemia. 2003. PMID: 12835738 No abstract available.

7

Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs.

Kreth K, Kovar K, Schwab M, Zanger UM. Kreth K, et al. Among authors: schwab m. Biochem Pharmacol. 2000 Jun 15;59(12):1563-71. doi: 10.1016/s0006-2952(00)00284-7. Biochem Pharmacol. 2000. PMID: 10799653

8

[Pharmacogenomics: hype or hope?].

Schwab M, Schaeffeler E, Zanger UM, Brauch H, Kroemer HK. Schwab M, et al. Dtsch Med Wochenschr. 2011 Mar;136(10):461-7. doi: 10.1055/s-0031-1274528. Epub 2011 Mar 1. Dtsch Med Wochenschr. 2011. PMID: 21365522 Review. German.

9

Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?

Emami-Riedmaier A, Schaeffeler E, Nies AT, Mörike K, Schwab M. Emami-Riedmaier A, et al. Among authors: schwab m. J Intern Med. 2015 Feb;277(2):235-247. doi: 10.1111/joim.12330. J Intern Med. 2015. PMID: 25418285 Free article. Review.

10

Pretreatment determination of TPMT--state of the art in clinical practice.

Teml A, Schaeffeler E, Schwab M. Teml A, et al. Among authors: schwab m. Eur J Clin Pharmacol. 2009 Mar;65(3):219-21. doi: 10.1007/s00228-009-0618-7. Epub 2009 Feb 7. Eur J Clin Pharmacol. 2009. PMID: 19198820 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,876 results

Search Page